NCT00341224 is a Phase 2 clinical trial of Group-mentoring intervention in Mentoring, sponsored by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD).

What drugs are being tested in NCT00341224?

Interventions in NCT00341224: Group-mentoring intervention.

Is NCT00341224 still recruiting?

NCT00341224 is currently completed. Last updated 2 July 2017.

Last reviewed 2017-07-02 · How we verify

NCT00341224

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Steppin' Up: Positive Youth Development Program

Completed Phase 2 Last updated 2 July 2017

What this trial tests

Phase 2 trial testing Group-mentoring intervention in Mentoring. Completed in 9 December 2009.

Timeline

23 July 2003

Primary endpoint
9 December 2009

9 December 2009

Quick facts

Lead sponsor	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Start date	23 July 2003
Primary completion	9 December 2009
Estimated completion	9 December 2009
Sites	1 location across United States

Drugs / interventions tested

Group-mentoring intervention

Conditions studied

Mentoring — all drugs for Mentoring →

Sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Who can join

12 and older, any sex, with Mentoring. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

As an antidote to juvenile aggression and violence, which has increased in recent years, group mentoring offers a viable alternative to intensive one-on-one mentoring. However, no group-mentoring programs have been evaluated. The purpose of this study is to assess the efficacy of a school-based, group-mentoring intervention designed to prevent aggressive and deviant behavior among early adolescents. Study participants will be incoming 6th grade students from two inner-city Baltimore middle schools and their parents. Approximately 1,400 students and their parents are expected to participate. All 6th grade students in these schools are eligible for the study. Weekly student group-mentoring sessions are the principal component of this study. These groups will be held during the school day and will be designed to increase social skills and encourage academic engagement, restraint, and problem-solving. A master's level professional will direct and conduct these intervention activities, which will employ the use of field trips, cooperative games, discussion of real-life situations, and role playing. Students will also complete a 1-hour written survey each fall and spring from grades 6-8 about the program and about attitudes and behaviors related to school involvement and staying healthy and safe. Study staff will contact participants' teachers and review their past and current school records, including attendance, grades, and disciplinary information. Parents may be asked to participate in group meetings and will complete in-person or telephone interviews (about 20 minutes each) about similar information over a 3-year period (6th grade to 8th grade).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Mentoring

Currently open trials in the same condition.

NCT06089239 — Choosing Wisely: De-implementing Fall Prevention Alarms in Hospitals · NA · recruiting

Other Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) trials

Trials by the same sponsor.

NCT07502586 — Turner Syndrome: Genetic Considerations · recruiting
NCT07357701 — Identifying Genome Variants in Non-Obstructive Azoospermia (NOA) or Primary Ovarian Insufficiency (POI) · recruiting
NCT06851754 — Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency · Phase 3 · recruiting
NCT05548881 — Implications of Maternal 45,X Mosaicism as a Secondary Genomic Finding Following Cell-Free DNA Sequencing During Pregnan · withdrawn
NCT06749366 — Uncovering Genes Behind Cartilage Tumors and Vascular Anomalies Using Genomic Sequencing · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00341224 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Last refreshed: 2 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00341224.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing